Citigroup analyst Itay Michaeli maintains Tesla (NASDAQ:TSLA) with a Neutral and raises the price target from $137 to $146.
Eisai-Biogen Seek Complete FDA Approval For Its Second Alzheimer’s Treatment
The FDA has accepted Eisai Co Ltd (OTC:ESALY) and Biogen Inc’s (NASDAQ:BIIB) supplemental Biologics License Application (sBLA) for Leqembi (lecanemab-irmb) 100 mg/mL injection,…